Prostate cancer is common. Many cases are slow-growing and safely observed; others are aggressive and need treatment. Deciding which group a particular cancer falls into drives every subsequent step.
The prostate is a walnut-sized gland that sits below the bladder and surrounds the start of the urethra. It produces part of the fluid that makes up semen. Prostate cancer arises from the glandular tissue of the prostate, most commonly in the peripheral zone.
Staging determines whether the cancer is still confined to the prostate (localised), has extended into surrounding structures (locally advanced), or has spread (metastatic). Tools include mpMRI for local extent and, for intermediate- and high-risk disease, PSMA-PET/CT for staging of nodes and distant sites.
For men who choose surgery, robotic prostatectomy offers equivalent cancer control to open surgery in contemporary series, with lower blood loss, shorter hospital stay and often earlier return of urinary continence.4,5 The choice of surgery vs radiotherapy vs surveillance is separate from the choice of surgical platform; the right first conversation is about which treatment category suits the cancer and the person.
You can request a second opinion on imaging, staging and treatment options before you decide. General information only; not individual medical advice.